United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $927,578,904.60
- Sept. 24, 2025
- Martine A Rothblatt
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 13, 2017 | CEO | 1,258 | $122.12 | Sell | $153,626.96 | |
| April 6, 2017 | CEO | 1,257 | $122.39 | Sell | $153,844.23 | |
| March 30, 2017 | CEO | 1,230 | $134.56 | Sell | $165,508.80 | |
| March 23, 2017 | CEO | 1,219 | $139.33 | Sell | $169,843.27 | |
| March 22, 2017 | Director | 2,000 | $139.37 | Sell | $278,740.00 | |
| March 16, 2017 | CEO | 1,218 | $140.16 | Sell | $170,714.88 | |
| March 9, 2017 | CEO | 1,206 | $146.72 | Sell | $176,944.32 | |
| March 2, 2017 | CEO | 1,203 | $148.49 | Sell | $178,633.47 | |
| Feb. 23, 2017 | CEO | 1,208 | $145.16 | Sell | $175,353.28 | |
| Feb. 16, 2017 | CEO | 1,173 | $167.92 | Sell | $196,970.16 | |
| Jan. 12, 2017 | CEO | 1,214 | $142.37 | Sell | $172,837.18 | |
| Jan. 12, 2017 | Director | 5,000 | $141.99 | Sell | $709,950.00 | |
| Jan. 5, 2017 | CEO | 1,208 | $145.73 | Sell | $176,041.84 | |
| Dec. 29, 2016 | CEO | 1,211 | $143.63 | Sell | $173,935.93 | |
| Dec. 22, 2016 | CEO | 1,218 | $140.23 | Sell | $170,800.14 | |
| Dec. 15, 2016 | CEO | 1,212 | $143.11 | Sell | $173,449.32 | |
| Dec. 8, 2016 | CEO | 1,236 | $131.78 | Sell | $162,880.08 | |
| Dec. 6, 2016 | Director | 5,000 | $133.37 | Sell | $666,850.00 | |
| Dec. 1, 2016 | CEO | 1,246 | $126.86 | Sell | $158,067.56 | |
| Nov. 25, 2016 | CEO | 1,233 | $132.81 | Sell | $163,754.73 | |
| Nov. 17, 2016 | CEO | 1,232 | $132.94 | Sell | $163,782.08 | |
| Nov. 10, 2016 | CEO | 1,240 | $129.82 | Sell | $160,976.80 | |
| Nov. 10, 2016 | Director | 5,000 | $131.42 | Sell | $657,100.00 | |
| Nov. 3, 2016 | CEO | 1,272 | $116.94 | Sell | $148,747.68 | |
| Oct. 27, 2016 | CEO | 1,272 | $117.06 | Sell | $148,900.32 | |
| Oct. 20, 2016 | CEO | 1,282 | $113.30 | Sell | $145,250.60 | |
| Oct. 13, 2016 | CEO | 1,269 | $117.99 | Sell | $149,729.31 | |
| Oct. 6, 2016 | CEO | 1,260 | $121.17 | Sell | $152,674.20 | |
| Sept. 29, 2016 | CEO | 1,272 | $116.94 | Sell | $148,747.68 | |
| Sept. 26, 2016 | Director | 1,291 | $125.57 | Sell | $162,110.87 | |
| Sept. 22, 2016 | CEO | 1,249 | $125.87 | Sell | $157,211.63 | |
| Sept. 15, 2016 | CEO | 1,258 | $122.34 | Sell | $153,903.72 | |
| Sept. 8, 2016 | CEO | 1,254 | $123.44 | Sell | $154,793.76 | |
| Sept. 1, 2016 | CEO | 1,257 | $122.81 | Sell | $154,372.17 | |
| Sept. 1, 2016 | Director | 5,000 | $122.73 | Sell | $613,650.00 | |
| Aug. 25, 2016 | CEO | 1,250 | $125.29 | Sell | $156,612.50 | |
| Aug. 18, 2016 | CEO | 1,249 | $125.88 | Sell | $157,224.12 | |
| Aug. 11, 2016 | CEO | 1,253 | $124.09 | Sell | $155,484.77 | |
| Aug. 4, 2016 | CEO | 1,249 | $125.78 | Sell | $157,099.22 | |
| July 28, 2016 | CEO | 1,271 | $117.05 | Sell | $148,770.55 | |
| July 21, 2016 | CEO | 1,284 | $112.77 | Sell | $144,796.68 | |
| July 14, 2016 | CEO | 1,292 | $110.05 | Sell | $142,184.60 | |
| July 7, 2016 | CEO | 1,293 | $109.87 | Sell | $142,061.91 | |
| June 30, 2016 | CEO | 1,308 | $105.10 | Sell | $137,470.80 | |
| June 23, 2016 | CEO | 1,312 | $104.07 | Sell | $136,539.84 | |
| June 16, 2016 | CEO | 1,308 | $105.18 | Sell | $137,575.44 | |
| June 9, 2016 | CEO | 1,277 | $114.99 | Sell | $146,842.23 | |
| June 8, 2016 | Director | 2,000 | $115.62 | Sell | $231,240.00 | |
| June 2, 2016 | CEO | 1,261 | $120.79 | Sell | $152,316.19 | |
| June 2, 2016 | Director | 3,000 | $118.82 | Sell | $356,460.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, Raymond Dwek, John Maxim Ferrari, Michael Benkowitz, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, Nilda Mesa, James Edgemond, Tommy G Thompson, Louis W Sullivan, Judy D Olian, Paul A. Mahon, Ray Kurzweil, DWEK RAYMOND, Tommy G. Thompson, Jan Malcolm, MAHON PAUL A, Louis Sullivan, Judy D. Olian, and R Paul Gray
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 393 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $386,981,200.91.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Sept. 24, 2025.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Louis W Sullivan with a total value of $9,781,722.98 on Dec. 18, 2024.
